Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros












Base de dados
Intervalo de ano de publicação
1.
Zhonghua Jie He He Hu Xi Za Zhi ; 47(7): 658-662, 2024 Jul 12.
Artigo em Chinês | MEDLINE | ID: mdl-38955752

RESUMO

Malignant peripheral nerve sheath tumor (MPNST) frequently metastasizes to the lungs, although pleural metastasis is rare. This article reported a case of pleural metastasis of MPNST. The patient was a young man who presented with 1 week of shortness of breath with dry cough. He had a history of malignant peripheral nerve sheath tumor. The patient was diagnosed with MPNST pleural metastasis after a thoracoscopic pleural biopsy, which revealed short spindle cell hyperplasia, immunohistochemical staining for S-100(+), SOX-10(+), Ki-67(+) with a positive index of 20%, and H3K27Me3(-) in the pleural pathology.


Assuntos
Neoplasias de Bainha Neural , Neoplasias Pleurais , Humanos , Masculino , Neoplasias Pleurais/secundário , Neoplasias Pleurais/patologia , Neoplasias de Bainha Neural/patologia , Neoplasias de Bainha Neural/secundário , Neoplasias de Bainha Neural/diagnóstico , Adulto
2.
Zhonghua Fu Chan Ke Za Zhi ; 59(5): 391-400, 2024 May 25.
Artigo em Chinês | MEDLINE | ID: mdl-38797569

RESUMO

Objective: To investigate the effect of rare ginsenosides (RGS) on reproductive injury induced by cyclophosphamide (CP) in female rats. Methods: Twenty-four female rats were divided into four groups [normal control (NC), RGS, CP, and CP+RGS group] with 6 rats in each group. CP group (the model group) and CP+RGS group (the treatment group) were intraperitoneally injected with CP 30 mg/kg for 5 days for modeling, and CP+RGS group was given RGS intragastric intervention. General growth status of rats in each group was observed, the organ index was calculated, and the pathological changes of ovary, uterus, liver and kidney were observed by hematoxylin-eosin staining. Serum levels of estradiol, follicle stimulating hormone (FSH), luteinizing hormone (LH), pro-inflammatory factors interleukin (IL) 6, IL-1ß, tumor necrosis factor-α were detected. The urine samples were collected after RGS treatment for metabonomics analysis. Metabolomic profiling based on ultra performance liquid chromatography (UPLC) coupled with mass spectrometry (MS) was used to analyze and determine the urine metabolites of rats in each group. Results: Compared with NC group, the ovary index of CP group [(0.054±0.015) %] was significantly decreased (P<0.05), the uterus index [(0.293±0.036) %] and estradiol level [(62.9±6.4) pmol/L] were significantly decreased (all P<0.01), serum levels of FSH, LH, IL-6 and IL-1ß [(20.4±1.0) U/L, (29.0±3.0) U/L, (185.4±28.6) ng/L, (72.9±2.0) ng/L, respectively] were significantly increased (all P<0.01). Compared with CP group, the ovary index in CP+RGS group [(0.075±0.010) %] was significantly increased (P<0.05), serum estradiol level [(122.1±16.2) pmol/L] was significantly increased (P<0.01), serum FSH, IL-1ß and IL-6 levels [(16.7±1.0) U/L, (111.8±17.4) ng/L, (60.1±2.2) ng/L, respectively] were significantly decreased (all P<0.01). Metabonomics analysis results showed that, a total of 352 metabolites were detected in urine, of which 12 were found to be potential markers associated with reproductive injury according to the screening standard. After treatment with RGS, differential metabolites were improved in the direction of NC group. Pathway enrichment suggests that the therapeutic effect of RGS was related to multiple metabolic pathways, including purine metabolism and taurine and hypotaurine metabolism. Conclusion: RGS might reduce inflammation and thus ameliorate the damage caused by CP to the reproductive system of female rats by affecting purine metabolism and other pathways.


Assuntos
Ciclofosfamida , Estradiol , Hormônio Foliculoestimulante , Ginsenosídeos , Metabolômica , Ovário , Ratos Sprague-Dawley , Útero , Animais , Feminino , Ratos , Ciclofosfamida/efeitos adversos , Ciclofosfamida/toxicidade , Ginsenosídeos/farmacologia , Hormônio Foliculoestimulante/sangue , Estradiol/sangue , Ovário/efeitos dos fármacos , Ovário/patologia , Ovário/metabolismo , Útero/efeitos dos fármacos , Útero/patologia , Útero/metabolismo , Hormônio Luteinizante/sangue , Cromatografia Líquida de Alta Pressão , Interleucina-6/metabolismo , Interleucina-6/sangue , Modelos Animais de Doenças , Interleucina-1beta/metabolismo , Interleucina-1beta/sangue , Fator de Necrose Tumoral alfa/metabolismo , Fator de Necrose Tumoral alfa/sangue , Fígado/metabolismo , Fígado/efeitos dos fármacos , Fígado/patologia , Espectrometria de Massas , Rim/efeitos dos fármacos , Rim/patologia , Rim/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...